IL1A and lung carcinoma: Accordingly, we discuss whether targeting of IL-1/IL-1 receptor (IL-1R) and/or tumor-supporting M2-type macrophages will offer useful therapeutic strategies for inhibition of tumor growth and lymph node metastasis, through suppression of lymphangiogenesis and angiogenesis by lung cancer cells.